Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Pruritus Therapeutics Market Size Changed, over the years?

The market for pruritus therapeutics has seen robust expansion in the past few years. Its size is predicted to escalate from $11.89 billion in 2024 to $12.51 billion in 2025, showcasing a compound annual growth rate (CAGR) of 5.3%. Factors influencing this growth trend in the historic period include an increase in pruritus cases, a variety of causes and conditions, a surge in the elderly population, and an emphasis on improving patient’s quality of life.

How Much Will the Pruritus Therapeutics Market Be Worth in 2029?

The market for pruritus therapeutics is forecasted to experience substantial growth in the coming years, with an estimated value of $16.05 billion by 2029 and a compound annual growth rate (CAGR) of 6.4%. Several factors will drive this anticipated growth, including a growing understanding of pruritus pathophysiology, innovation in drug formulations and delivery methods, an emphasis on personalized medicine, an increase in dermatological R&D, increased diagnosis rates, and a rising interest in plant-based and herbal treatments. Other key trends expected during this forecast period are the creation of itch-specific receptor agonists and antagonists, a market shift towards personalized therapeutic approaches, the inclusion of advanced technology in itch tracking and management, and increased collaboration for interdisciplinary research.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11907&type=smp

Which is the Largest Company in the Pruritus Therapeutics Market?

Major companies operating in the pruritus therapeutics market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Eli Lilly and Company, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc. , Bausch Health Companies Inc., Galderma Laboratories LP, Cipla Limited, LEO Pharma AS, Cara Therapeutics Inc., GlaxoSmithKline Plc, Novan Inc., Escient Pharmaceuticals Inc., Nerre Therapeutic Ltd., EPI Health LLC, Trevi Therapeutics Inc., Evelo Biosciences, Toray Medical Co. Ltd.

What Are the Main Market Drivers in the Pruritus Therapeutics Industry?

An increase in dermatological conditions is anticipated to boost the expansion of the pruritus therapeutics market. Dermatological conditions are an array of disorders affecting the skin, hair, nails, and mucous membrane; from acne and eczema to skin cancer and fungal infections. The choice of pruritus treatments for skin diseases is often guided by the underlying cause of the itch. Topical treatments, emollients and moisturizers, immunosuppressive drugs, and treatments specifically for itching are all options to manage this condition. For example, in January 2024, the American Cancer Society, a non-profit organization in the US with a mission to eradicate cancer, projected 108,270 skin cancer cases. This represented a 3.2% increase from the 104,930 cases reported in 2023. Consequently, the upsurge in the occurrence of dermatological conditions is steering the growth of the pruritus therapeutics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11907&type=smp

How Is the Pruritus Therapeutics Market Segments Structured?

The pruritus therapeutics market covered in this report is segmented –

1) By Product: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressants, Calcineurin Inhibitors, Other Products

2) By Route Of Administration: Oral, Parenteral, Topical

3) By Disease Type: Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types

4) By End-User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids

2) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines

3) By Local Anesthetics: Topical Local Anesthetics

4) By Counterirritants: Menthol-Based Products, Camphor-Based Products

5) By Immunosuppressants: Topical Immunosuppressants, Systemic Immunosuppressants

6) By Calcineurin Inhibitors: Tacrolimus Ointment, Pimecrolimus Cream

7) By Other Products: Moisturizers And Emollients, Antipruritic Herbal Remedies, Combination Therapies

What Strategic Trends Are Transforming the Pruritus Therapeutics Market?

Leading firms in the pruritus therapeutics market are concentrating on creating customized treatments for specific patient groups and rare diseases, like the non-systemic ileal bile acid transport inhibitor to offer individualized medicine addressing unaddressed healthcare needs. This specific drug type homes in on bile acid absorption in the intestine without greatly influencing the systemic circulation, hence reducing possible side effects. For example, in June 2023, Ipsen, a pharmaceutical company based in France, was granted approval by the Food and Drug Administration (FDA), the US federal agency under the Department of Health and Human Services, for Bylvay (odevixibat) to cure cholestatic pruritus in patients who are 12 months or older and suffer from Alagille syndrome (ALGS). Bylvay, an everyday, non-systemic ileal bile acid transport inhibitor (IBATi) with minimal systemic exposure, is the pioneering drug approved for cholestatic pruritus due to progressive familial intrahepatic cholestasis (PFIC) in America. Prior to this, it had been approved for PFIC treatment in Europe and is currently accessible via prescription for suitable ALGS patients.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pruritus-therapeutics-global-market-report

Which Global Regions Offer the Highest Growth in the Pruritus Therapeutics Market?

North America was the largest region in the pruritus treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pruritus therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11907

This Report Delivers Insight On:

1. How big is the pruritus therapeutics market, and how is it changing globally?

2. Who are the major companies in the pruritus therapeutics market, and how are they performing?

3. What are the key opportunities and risks in the pruritus therapeutics market right now?

4. Which products or customer segments are growing the most in the pruritus therapeutics market?

5. What factors are helping or slowing down the growth of the pruritus therapeutics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model